Lidilhone Hamerski

Prof. Lidilhone Hamerski

orcid

Research Focus & Metrics

Academic Career Length

17Years (2010-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
7 August 2020 in Journal of Fungi
Verified
Journal Article
Open access
PDF file
JCJacqueline Cruz
Jacqueline Cruz
CSCarla Amaral da Silva
Carla Amaral da Silva
LHLidilhone Hamerski
Lidilhone Hamerski
This review presents the chemical diversity and pharmacological properties of secondary metabolites produced by endophytic fungi associated with various genera of Rubiaceae. Several classes of natural products are described for these endophytes, although, this study highlights the importance of some metabolites, which are involved in antifungal, antibacterial, anti-protozoal activities; neurodegenerative diseases; cytotoxic activity; anti-inflammatory and antioxidant activity; and hyperglycemic control.

13 June 2019 in RSC Advances
Verified
Journal Article
Open access
PDF file
CNCharlotte Nirma
Charlotte Nirma
GRGregorio Torres Rangel
Gregorio Torres Rangel
MAMarina Amaral Alves
Marina Amaral Alves
LCLivia Marques Casanova
Livia Marques Casanova
MMMayara Monteiro Moreira
Mayara Monteiro Moreira
Luzineide TinocoLuzineide Tinoco
Luzineide Tinoco
This study presents new inhibitors of the nucleoside hydrolase from Leishmania donovani (LdNH) with in vitro leishmanicidal activity. Biological screening of 214 Brazilian plant extracts was performed to select plants with enzyme inhibitory activity. Two plants were selected for their results, and for their lack of prior phytochemical description: Leandra amplexicaulis DC. (Melastomataceae) and Urvillea rufescens Cambess (Sapindaceae). Three flavonoids were isolated by bioguided fractionation of the hydroethanolic extracts: kaempferol 3-O-α-L-rhamnopyranoside (1) and kaempferol 3-O-β-D-xylopyranosyl-(1→2)-α-L-rhamnopyranoside (2) from L. amplexicaulis, as well as tricetin-4′-O-methyl flavone (3) from U. rufescens. These flavonoids showed inhibitory activities (IC50) of 197.4 μM (1), 74.7 μM (2) and 1.1 μM (3) on the LdNH. Their binding mode was proposed based on molecular docking with LdNH and by NMR Saturation Transfer Difference studies. Kinetic studies demonstrate that the most potent inhibitor (3) acts by uncompetitive inhibition. This study reports for the first time the inhibition of LdNH by naturally sourced flavonoids.

1 April 2021 in Phytochemistry Letters
Verified
Journal Article
Closed access
CNCláudio Rodrigo Nogueira
Cláudio Rodrigo Nogueira
LHLidilhone Hamerski
Lidilhone Hamerski
COCaroline Tieppo Flores de Oliveira
Caroline Tieppo Flores de Oliveira
WGWalmir Silva Garcez
Walmir Silva Garcez
FGFernanda Garcez
Fernanda Garcez

1 April 2023 in Mini-Reviews in Medicinal Chemistry
Verified
Journal Article
Closed access
PDF file
PPPaulo Cézar Prado
Paulo Cézar Prado
JLJosélia Lima
Josélia Lima
LHLidilhone Hamerski
Lidilhone Hamerski
MRMagdalena Nascimento Rennó
Magdalena Nascimento Rennó
Alzheimer’s disease (AD) is a neurodegenerative, progressive, and fatal disorder characterized by marked atrophy of the cerebral cortex and loss of basal forebrain cholinergic neurons. The main pathological features of AD are related to neuronal degeneration and include extracellular deposition of amyloid beta plaques (Aβ plaques), intracellular formation of neurofibrillary tangles (NFTs), and neuroinflammation. So far, drugs used to treat AD have symptomatic and palliative pharmacological effects, disappearing with continued use due to neuron degeneration and death. Therefore, there are still problems with an effective drug for treating AD. Few approaches evaluate the action of natural products other than alkaloids on the molecular targets of β-amyloid protein (Aβ protein) and/or tau protein, which are important targets for developing neuroprotective drugs that will effectively contribute to finding a prophylactic drug for AD. This review gathers and categorizes classes of natural products, excluding alkaloids, which in silico analysis (molecular docking) and in vitro and/or in vivo assays can inhibit the BACE1 and GSK-3β enzymes involved in AD.

31 December 2010 in Biochemical Systematics and Ecology
Verified
Journal Article
Closed access
WGWalmir Garcez
Walmir Garcez
FGFernanda Garcez
Fernanda Garcez
CTCaroline Tieppo
Caroline Tieppo
OFOsmar Nunes de Freitas
Osmar Nunes de Freitas
LHLidilhone Hamerski
Lidilhone Hamerski

17 December 2019 in Journal of Applied Toxicology
Verified
Journal Article
Closed access
PDF file
RCRaphael de Mello Carpes
Raphael de Mello Carpes
MAMatteus de Assis Alves
Matteus de Assis Alves
JCJoel Creed
Joel Creed
CSCarla Amaral da Silva
Carla Amaral da Silva
LHLidilhone Hamerski
Lidilhone Hamerski
IFIsrael Felzenszwalb
Israel Felzenszwalb